US EditionFirst procedures performed in FRACTURE trial of Bolt IVL system in coronary artery disease - Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
FRACTURE Trial of Boston Scientific’s Bolt IVL System Begins Enrollment in United States - Cardiac Interventions Today
July 3, 2025—Boston Scientific recently announced that it has commenced United States enrollment in the global FRACTURE investigational device exemption trial. The study will assess the safety and efficacy of the Bolt Medical intravascular lithotripsy (IVL) system in patients undergoing percutaneous coronary intervention for the treatment of coronary artery disease with severely calcified lesions. Brian K. Jefferson, MD, from TriStar Centennial …
First procedures performed in FRACTURE trial of Bolt IVL system in coronary artery disease - Cardiovascular News
Boston Scientific’s global headquarters in Marlborough, USA The first US procedures have been performed in the FRACTURE investigational device exemption (IDE) trial of the Bolt intravascular lithotripsy (IVL) system in patients undergoing percutaneous coronary intervention (PCI) for the treatment of coronary artery disease in severely calcified lesions. Brian K Jefferson, a physician at TriStar Centennial Medical Center (Nashville, USA) and inve…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
